Notably, BC tissues had the highest expression of Src across 33 types of cancers, and Asians had higher expression levels of Src in BC (Fig. 7b, d), indicating a higher likelihood of benefitting from dasatinib for BC patients in Asia. This evidence concerns the gene SRC and cancer.